Dr Stefan Laspina

Dr Stefan Laspina

Dr Stefan Laspina

  M.D.(Melit), PhD(Warwick), F.F.Path(Ireland), F.R.C.Path.(UK)

Visiting Senior Lecturer

Medical School, Mater Dei Hospital
Msida
__Biography
__ResearchInterests

ATTARD, J., BRINCAT, M., TANTI, C., BUHAGIAR, N., FARRUGIA, M., FARRUGIA, J., LASPINA, S., MUSCAT BARON, Y., MICALLEF, R. and MARMARA, D., 2020. Charting the Endometrial Cancer Care Pathway. Malta Medical Journal, 32(1),.

JUNG-KONIG, M., FULLENBACH, C., MURPHY, M., MANZINI, P., LASPINA, S., PENDRY, K., MUHLING, J., WIKMAN, A., HUMBRECHT, C., RIGAL, J., LASOCKI, S., FOLLEA, G., SEIFRIED, E., MULLER, M., GEISEN, C., ARANKO, K., ZACHAROWSKI, K. and MEYBOHM, P., 2020. Programmes for the management of preoperative anaemia: audit in ten European hospitals within the PaBloE (Patient Blood Management in Europe) Working Group. Vox Sanguinis, 115(3), pp. 182.

GARRAUD, O., BRAND, A., HENSCHLER, R., VUK, T., HADDAD, A., LOZANO, M., ERTUĞRUL ÖRÜÇ, N., POLITIS, C., DE ANGELIS, V., LASPINA, S. and TISSOT, J., 2018. Medical student education in transfusion medicine: Proposal from the "European and Mediterranean initiative in transfusion medicine".

MANZINI, P.M., DALL'OMO, A.M., D'ANTICO, S., VALFRÈ, A., PENDRY, K., WIKMAN, A., FISCHER, D., BORG-AQUILINA, D., LASPINA, S., VAN PAMPUS, E.C.M., VAN KRAAIJ, M., BRUUN, M.T., GEORGSEN, J., GRANT-CASEY, J., BABRA, P.S., MURPHY, M.F., FOLLÉA, G. and ARANKO, K., 2018. Patient blood management knowledge and practice among clinicians from seven European university hospitals: a multicentre survey. Vox sanguinis, 113(1), pp. 60-71.

MIFSUD, A., PEELEN, D., BRINCAT, P., ABELA, S., DEBATTISTA, N., LASPINA, S., ZAMMIT, D., CAMILLERI, D.J. and GATT, A., 2016. A feasibility study on the effects of Triton X-100 for the in vitro inactivation of Ebola virus on haematological assays. Journal of clinical pathology, 69(7), pp. 637.

LASPINA, S., 2015. The Sir Anthony Mamo Oncology Centre. Malta Journal of Health Sciences.

GATT, A., BONELLO, F., BUTTIGIEG, R., DEBONO, S., BRINCAT, P., GRIMA, C., GATT, P., LOFARO, T. and LASPINA, S., 2014. Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies. Blood transfusion = Trasfusione del sangue, 12(4), pp. 479.

DEBONO, S., BONELLO, F., BUTTIGIEG, R., BRINCAT, P., GRIMA, C., LOFARO, T., LASPINA, S. and GATT, A., 2013. Utility of teg and flowcytometry to guide platelet transfusion requirement in patients with haematological malignancies. Journal of Thrombosis and Haemostasis, 11(SI), pp. 74.

MCCLELLAND, D.B.L., PIRIE, E. and FRANKLIN, I.M. FOR THE EU OPTIMAL USE OF BLOOD PROJECT PARTNERS, eds, 2010. Manual of Optimal Blood Use. Scotland: Scottish National Blood Transfusion Service.

LUNDY, D., LASPINA, S., KAPLAN, H., RABIN FASTMAN, B. and LAWLOR, E., 2007. Seven hundred and fifty‐nine (759) chances to learn: a 3‐year pilot project to analyse transfusion‐related near‐miss events in the Republic of Ireland. Vox sanguinis, 92(3), pp. 233-241.

PICCIN, A., RAIMONDI, R., LASPINA, S., MARCHI, M., RODEGHIERO, F. and ROVIGATTI, U., 2007. Erythroleukaemia, diabetes insipidus and hypophyseal damage: Two case reports. Leukaemia Research, 31, pp. 1143.

ENGELFREIT CP, R.H., 2006. International Forum: Haemovigilance. Vox Sanguinis, 90, pp. 207.

ROONEY, G., DUNNE, C., LASPINA, S., LAWLOR, E., WOOLFSON, M., CUMMINS, F. and GOUGH, D., 2006. Provision of HLA matched platelets using HILAMatchmaker. Tissue Antigens, 67(6), pp. 560.

LASPINA, S., O'RIORDAN, J.M., LAWLOR, E. and MURPHY, W.G., 2005. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin. Vox sanguinis, 89(1), pp. 49-51.

LASPINA, S.J., BROWNE, M.A., MCSWEENEY, E.N., LAWLOR, J., WHELAN, D.M., KINSELLA, A.I. and MURPHY, W.G., 2002. QT c prolongation in apheresis platelet donors. Transfusion, 42(7), pp. 899-903.

__Other

https://www.um.edu.mt/_templates/staffprofilesnopic/